Idexx Laboratories (IDXX) Income from Non-Controlling Interests (2010 - 2021)
Idexx Laboratories (IDXX) recorded quarterly Income from Non-Controlling Interests of -$57000.0 in Q3 2021, down 337.5% quarter-over-quarter from $24000.0 in Q2 2021, and down 155.88% on a YoY basis from $102000.0 in Q3 2020.
Idexx Laboratories (IDXX) Income from Non-Controlling Interests (2010 - 2021) Analysis & Trends
Idexx Laboratories' Income from Non-Controlling Interests history runs 12 years deep, the most recent figure standing at -$57000.0 for Q3 2021.
- In Q3 2021, Income from Non-Controlling Interests fell 155.88% year-over-year to -$57000.0; the TTM figure through Jun 2022 stood at -$57000.0 (down 117.48% YoY), while the FY2021 annual figure was -$1000.0, down 100.28% from the prior year.
- Income from Non-Controlling Interests was -$57000.0 for Q3 2021 at Idexx Laboratories, down from $24000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $168000.0 in Q4 2020 to a low of -$57000.0 in Q3 2021.
- Historically, Income from Non-Controlling Interests has averaged $29842.1 across 5 years, with a median of $29000.0 in 2020.
- The sharpest annual moves came in 2018 and 2020: Income from Non-Controlling Interests plunged 1333.33% in 2018, then jumped 10100.0% in 2020.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $33000.0 in 2017, then increased by 18.18% to $39000.0 in 2018, then climbed by 23.08% to $48000.0 in 2019, then surged by 250.0% to $168000.0 in 2020, then tumbled by 133.93% to -$57000.0 in 2021.
- The last three Income from Non-Controlling Interests figures came in at -$57000.0 (Q3 2021), $24000.0 (Q2 2021), and $32000.0 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 1.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 22.46 Bn | 22.36 Bn | 942.00 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -57,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 32,000.00 |
| Dec 31, 2020 | 168,000.00 |
| Sep 30, 2020 | 102,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Mar 31, 2020 | 29,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | -5,000.00 |
| Mar 31, 2019 | 28,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | -37,000.00 |
| Jun 30, 2018 | -11,000.00 |
| Mar 31, 2018 | 25,000.00 |
| Dec 31, 2017 | 33,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 39,000.00 |
| Dec 31, 2016 | 2,000.00 |